Psychiatry Archives -

Tribunal maintains Lexon’s £1.2m fine for breaking competition law

https://pharmaphorum.com/news/tribunal-maintains-lexons-1-2m-fine-for-breaking-competition-law/

US eyes permanent change to digital health regulatory path

https://pharmaphorum.com/news/us-eyes-permanent-change-to-digital-health-regulatory-path/

Biogen bulks up pipeline with Sage drugs in $3bn deal

https://pharmaphorum.com/news/biogen-bulks-up-pipeline-with-sage-drugs-in-3bn-deal/

Blue Oak taps AI specialist Exscientia for CNS drug discovery

https://pharmaphorum.com/news/blue-oak-taps-ai-specialist-exscientia-for-cns-drug-discovery/

Pear rolls out digital therapy for schizophrenia under FDA’s COVID-19 scheme

https://pharmaphorum.com/news/pear-rolls-out-digital-therapy-for-schizophrenia-under-fdas-covid-19-scheme/

NICE rejects J&J’s Spravato for treatment-resistant depression

https://pharmaphorum.com/news/nice-rejects-jjs-spravato-for-treatment-resistant-depression/

J&J seeks wider use of its Spravato antidepressant in US

https://pharmaphorum.com/news/jj-seeks-wider-use-of-its-spravato-antidepressant-in-us/

Looking back, looking forward – Janssen’s 60 years on the psychiatry horizon

https://pharmaphorum.com/views-and-analysis/janssen-mental-health-psychiatry/

Search